| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Laboratory of Immunology* and the Pathology Service,¶ Heart Institute (InCor),University of São Paulo, São Paulo, Brazil; the Division of Clinical Immunology and Allergy, University of São Paulo School of Medicine, São Paulo, Brazil; the Department of Immunology,|| University of São Paulo School of Medicine–Ribeirão Preto, São Paulo, Brazil; the Institute for Investigation in Immunology/Millenium Institutes, São Paulo, Brazil; and Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
Chronic Chagas’ disease cardiomyopathy is a leading cause of congestive heart failure in Latin America, affecting more than 3 million people. Chagas’ cardiomyopathy is more aggressive than other cardiomyopathies, but little is known of the molecular mechanisms responsible for its severity. We characterized gene expression profiles of human Chagas’ cardiomyopathy and dilated cardiomyopathy to identify selective disease pathways and potential therapeutic targets. Both our customized cDNA microarray (Cardiochip) and real-time reverse transcriptase-polymerase chain reaction analysis showed that immune response, lipid metabolism, and mitochondrial oxidative phosphorylation genes were selectively up-regulated in myocardial tissue of the tested Chagas’ cardiomyopathy patients. Interferon (IFN)-
-inducible genes represented 15% of genes specifically up-regulated in Chagas’ cardiomyopathy myocardial tissue, indicating the importance of IFN- signaling. To assess whether IFN- can directly modulate cardio-myocyte gene expression, we exposed fetal murine cardiomyocytes to IFN- and the IFN--inducible chemokine monocyte chemoattractant protein-1. Atrial natriuretic factor expression increased 15-fold in response to IFN- whereas combined IFN- and monocyte chemoattractant protein-1 increased atrial natriuretic factor expression 400-fold. Our results suggest IFN- and chemokine signaling may directly up-regulate cardiomyocyte expression of genes involved in pathological hypertrophy, which may lead to heart failure. IFN- and other cytokine pathways may thus be novel therapeutic targets in Chagas’ cardiomyopathy.
This article has been cited by other articles:
 |
|
 |
|
  K. Reifenberg, H.-A. Lehr, M. Torzewski, G. Steige, E. Wiese, I. Kupper, C. Becker, S. Ott, P. Nusser, K.-I. Yamamura, et al. Interferon-{gamma} Induces Chronic Active Myocarditis and Cardiomyopathy in Transgenic Mice Am. J. Pathol., August 1, 2007; 171(2): 463 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. E. A. Souza, M. O. C. Rocha, C. A. S. Menezes, J. S. Coelho, A. C. L. Chaves, K. J. Gollob, and W. O. Dutra Trypanosoma cruzi Infection Induces Differential Modulation of Costimulatory Molecules and Cytokines by Monocytes and T Cells from Patients with Indeterminate and Cardiac Chagas' Disease Infect. Immun., April 1, 2007; 75(4): 1886 - 1894. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ashrafian and H. Watkins Reviews of Translational Medicine and Genomics in Cardiovascular Disease: New Disease Taxonomy and Therapeutic Implications: Cardiomyopathies: Therapeutics Based on Molecular Phenotype J. Am. Coll. Cardiol., March 27, 2007; 49(12): 1251 - 1264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Marin-Neto, E. Cunha-Neto, B. C. Maciel, and M. V. Simoes Pathogenesis of Chronic Chagas Heart Disease Circulation, March 6, 2007; 115(9): 1109 - 1123. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
